Yiwei Li - FDA Investigator Report

Overview Statistics

6
Total Inspections
6
Total 483s Issued
0
Warning Letters Issued

Inspection Details

Longest Inspection: 18 days
Shortest Inspection: 4 days
Average Length: 10.3 days

Discover the bigger picture. This is just the tip of the iceberg.

Gain access to comprehensive analysis, detailed reports, AI assistant, and much more.

Schedule a Demo

Yiwei Li's Recent Inspections

DateCompanyCityCountryFEI Number483
2025-04-10Aurolife Pharma LLCDurhamUnited States3014028588
2024-07-30Samsung Biologics Co., Ltd.YeonsuKorea (the Republic of)3010479596
2024-06-25STGEN BIO CO., LTD.YeonsuKorea (the Republic of)3025416433
2024-02-20Simtra US LLCBloomingtonUnited States1000115571
2023-12-14Suzhou Suncadia Biopharmaceuticals Co., LtdSuzhouChina3015786877
2023-06-16Beigene (Suzhou) Co., Ltd.SuzhouChina3014150588

Sign Up to get the complete report.

Download 483s and EIRs for Yiwei Li

Yiwei Li - Co-Inspectors

NameInspectionsLast Inspection
Laurimer Kuilan-Torres22025
Zhong Li22024
Andrea Franco12024
Charles Y Kuo12024
Jeanne M Fringer12024
Ruo H Xu12024
Richard Ledwidge12023
Tonia F Bernard12023

Yiwei Li's Active Locations

  • United States
  • China
  • Korea (the Republic of)

Yiwei Li's Year-wise Inspection Count

  • 2023:2 inspections
  • 2024:3 inspections
  • 2025:1 inspections
Last Updated: 2025-05-14 06:11:22